Rafferty Asset Management, LLC Intra Cellular Therapies, Inc. Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 5,820 shares of ITCI stock, worth $498,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,820
Previous 5,951 2.2%
Holding current value
$498,715
Previous $407,000 4.42%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$67.99 - $80.84 $8,906 - $10,590
-131 Reduced 2.2%
5,820 $425,000
Q2 2024

Aug 13, 2024
SELL
$64.76 - $79.84 $101,414 - $125,029
-1,566 Reduced 20.83%
5,951 $407,000
Q1 2024

May 13, 2024
BUY
$64.37 - $75.65 $46,668 - $54,846
725 Added 10.67%
7,517 $520,000
Q4 2023

Feb 13, 2024
BUY
$46.37 - $73.65 $24,390 - $38,739
526 Added 8.39%
6,792 $486,000
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $73,446 - $90,380
1,410 Added 29.04%
6,266 $326,000
Q2 2023

Aug 11, 2023
BUY
$54.67 - $66.44 $29,685 - $36,076
543 Added 12.59%
4,856 $307,000
Q1 2023

May 11, 2023
SELL
$43.8 - $56.99 $6,745 - $8,776
-154 Reduced 3.45%
4,313 $233,000
Q4 2022

Feb 13, 2023
SELL
$44.07 - $54.45 $11,193 - $13,830
-254 Reduced 5.38%
4,467 $236,000
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $10,717 - $15,057
251 Added 5.62%
4,721 $220,000
Q2 2022

Aug 12, 2022
SELL
$43.0 - $65.64 $127,968 - $195,344
-2,976 Reduced 39.97%
4,470 $255,000
Q1 2022

May 13, 2022
SELL
$38.74 - $62.09 $55,010 - $88,167
-1,420 Reduced 16.02%
7,446 $456,000
Q4 2021

Feb 10, 2022
SELL
$35.2 - $53.42 $24,041 - $36,485
-683 Reduced 7.15%
8,866 $464,000
Q3 2021

Nov 10, 2021
BUY
$28.72 - $42.49 $274,247 - $405,737
9,549 New
9,549 $356,000
Q1 2021

May 10, 2021
SELL
$30.8 - $39.51 $359,312 - $460,923
-11,666 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$23.34 - $32.22 $272,284 - $375,878
11,666 New
11,666 $371,000
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $79,719 - $214,485
-6,476 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$7.26 - $38.49 $44,256 - $234,635
-6,096 Reduced 48.49%
6,476 $222,000
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $93,912 - $176,385
12,572 New
12,572 $94,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.09B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email